Literature DB >> 12175708

Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors.

Christa E Müller1, Britta Schumacher, Axel Brattström, Ehab A Abourashed, Uwe Koetter.   

Abstract

Phytopharmaceuticals and dietary supplements containing valerian are used as mild sleep-inducing agents. An in vitro radioligand binding assay at A(1) and A(2A) adenosine receptors (ARs) was conducted with a fixed extract combination of valerian and hop (Ze 91019) to investigate a possible mechanism for the pharmacological activity of the extract. Component extracts of valerian and hop were also individually investigated. The fixed combination Ze 91019 as well as the valerian extracts therein exhibited selective affinity to A(1)ARs (K(i) = 0.15-0.37 mg/mL vs [(3)H]CCPA). The same extracts exhibited partial agonist activity at the A(1) adenosine receptor as indicated by a lower degree of stimulation of [35S]GTP gamma S binding in membrane preparations of CHO-hA(1) cells as compared to the full A(1) AR agonist N(6)-cyclopentyladenosine (CPA). In addition valerian extract inhibited cAMP accumulation in CHO-hA(1) cell membranes. The partial agonistic activity at A(1)ARs may thus play a role in the sleep inducing effect of Ze 91019 and the valerian extract therein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175708     DOI: 10.1016/s0024-3205(02)01964-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

Review 2.  [Sleep disorders in depression. Suggestions for a therapeutic approach].

Authors:  C Zimmermann; H Pfeiffer
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

3.  Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.

Authors:  Birgit M Dietz; Gail B Mahady; Guido F Pauli; Norman R Farnsworth
Journal:  Brain Res Mol Brain Res       Date:  2005-08-18

Review 4.  Complementary and alternative medicine for sleep disturbances in older adults.

Authors:  Nalaka S Gooneratne
Journal:  Clin Geriatr Med       Date:  2008-02       Impact factor: 3.076

5.  In vitro antioxidant activity of Valeriana officinalis against different neurotoxic agents.

Authors:  Jéssie Haigert Sudati; Roselei Fachinetto; Romaiana Picada Pereira; Aline Augusti Boligon; Margareth Linde Athayde; Felix Antunes Soares; Nilda Berenice de Vargas Barbosa; João Batista Teixeira Rocha
Journal:  Neurochem Res       Date:  2009-02-04       Impact factor: 3.996

6.  The Effects of Valerian on Sleep Quality, Depression, and State Anxiety in Hemodialysis Patients: A Randomized, Double-blind, Crossover Clinical Trial.

Authors:  Mohammad Reza Tammadon; Monir Nobahar; Zaynab Hydarinia-Naieni; Abbasali Ebrahimian; Raheb Ghorbani; Abbas Ali Vafaei
Journal:  Oman Med J       Date:  2021-03-31

Review 7.  Scientific evidence for a fixed extract combination (Ze 91019) from valerian and hops traditionally used as a sleep-inducing aid.

Authors:  Axel Brattström
Journal:  Wien Med Wochenschr       Date:  2007

Review 8.  Updates on Nutraceutical Sleep Therapeutics and Investigational Research.

Authors:  Michael Yurcheshen; Martin Seehuus; Wilfred Pigeon
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-21       Impact factor: 2.629

9.  The effects of Valeriana officinalis L. hydro-alcoholic extract on depression like behavior in ovalbumin sensitized rats.

Authors:  Ali Neamati; Fariba Chaman; Mahmoud Hosseini; Mohammad Hossein Boskabady
Journal:  J Pharm Bioallied Sci       Date:  2014-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.